paclitaxel has been researched along with Facial Palsy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, T; Kikuchi, M; Kosaka, Y; Minatani, N; Nishimiya, H; Sengoku, N; Tanino, H; Waraya, M; Watanabe, M | 1 |
| Bhuta, S; Head, CS; Nabili, V; Sercarz, JA; Tan, JW | 1 |
| Balmaceda, C; Hesdorffer, CS; Lee, RT; Oster, MW; Papadopoulos, KP; Vahdat, LT | 1 |
3 other study(ies) available for paclitaxel and Facial Palsy
| Article | Year |
|---|---|
[A case of facial nerve palsy induced by nab-paclitaxel].
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diphosphonates; Facial Paralysis; Female; Humans; Imidazoles; Middle Aged; Paclitaxel; Zoledronic Acid | 2013 |
Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ductal; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Facial Paralysis; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiotherapy, Adjuvant; Receptor, ErbB-2; Retrospective Studies; Salivary Gland Neoplasms; Trastuzumab | 2007 |
Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Facial Paralysis; Female; Humans; Middle Aged; Paclitaxel; Risk Factors | 1999 |